{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:02:08Z","timestamp":1792058528707,"version":"4.4.0"},"reference-count":166,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2004,9,1]],"date-time":"2004-09-01T00:00:00Z","timestamp":1093996800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2004,9]]},"DOI":"10.1016\/j.bcp.2004.05.031","type":"journal-article","created":{"date-parts":[[2004,7,24]],"date-time":"2004-07-24T10:25:55Z","timestamp":1090664755000},"page":"1089-1100","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":332,"title":["Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention"],"prefix":"10.1016","volume":"68","author":[{"given":"Kyung-Soo","family":"Chun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Joon","family":"Surh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1\u20132","key":"10.1016\/j.bcp.2004.05.031_BIB1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0300-483X(01)00443-7","article-title":"From carcinogenesis to clinical interventions for cancer prevention","volume":"166","author":"Greenwald","year":"2001","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0065-230X(08)61026-X","article-title":"Perspectives on cancer chemoprevention research and drug development","volume":"78","author":"Kelloff","year":"2000","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB3","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/BF02358623","article-title":"Cyclooxygenase, NSAIDs, and colorectal cancer","volume":"31","author":"DuBois","year":"1996","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB4","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/BF02055161","article-title":"Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis","volume":"40","author":"Winde","year":"1997","journal-title":"Dis. Colon Rectum."},{"key":"10.1016\/j.bcp.2004.05.031_BIB5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1006\/abbi.1993.1601","article-title":"Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression","volume":"307","author":"Feng","year":"1993","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bcp.2004.05.031_BIB6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/bjc.1980.31","article-title":"Prostaglandin-like material extracted from squamous cell carcinomas of the head and neck","volume":"41","author":"Bennett","year":"1980","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2004.05.031_BIB7","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/bjc.1982.298","article-title":"Prostaglandins and human lung carcinomas","volume":"46","author":"Bennett","year":"1982","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2004.05.031_BIB8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1288\/00005537-198503000-00014","article-title":"Prostaglandins in squamous cell carcinoma of the head and neck: a preliminary study","volume":"95","author":"Jung","year":"1985","journal-title":"Laryngoscope"},{"key":"10.1016\/j.bcp.2004.05.031_BIB9","unstructured":"Sano H, Kawahito Y, Wilder RL, Hashiramoto A, Mukai S, Asai K, et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res 1995;55:3785\u20139."},{"key":"10.1016\/j.bcp.2004.05.031_BIB10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/0016-5085(94)90246-1","article-title":"Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas","volume":"107","author":"Eberhart","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF00915791","article-title":"Regulation of immune response by prostaglandins","volume":"3","author":"Goodwin","year":"1983","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/0092-8674(95)90127-2","article-title":"Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2","volume":"83","author":"Tsujii","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB13","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0092-8674(00)81433-6","article-title":"Cyclooxygenase regulates angiogenesis induced by colon cancer cells","volume":"93","author":"Tsujii","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB14","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1172\/JCI9621","article-title":"Host cyclooxygenase-2 modulates carcinoma growth","volume":"105","author":"Williams","year":"2000","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.bcp.2004.05.031_BIB15","first-page":"2556","article-title":"Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis","volume":"56","author":"Boolbol","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/carcin\/18.3.491","article-title":"Inhibition of lung tumorigenesis by sulindac: comparison of two experimental protocols","volume":"18","author":"Castonguay","year":"1997","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2004.05.031_BIB17","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1002\/1097-0142(19951001)76:7<1116::AID-CNCR2820760703>3.0.CO;2-I","article-title":"Aspirin and reduced risk of esophageal carcinoma","volume":"76","author":"Funkhouser","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.bcp.2004.05.031_BIB18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","article-title":"Aspirin and the risk of colorectal cancer in women","volume":"333","author":"Giovannucci","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2004.05.031_BIB19","first-page":"1733","article-title":"Chemoprevention of intestinal polyposis in Apc delta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor","volume":"61","author":"Oshima","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB20","first-page":"1464","article-title":"Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent","volume":"55","author":"Rao","year":"1995","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB21","first-page":"5340","article-title":"Dose-related inhibition of colon carcinogenesis by dietary piroxicam, a nonsteroidal antiinflammatory drug during different stages of rat colon tumor development","volume":"47","author":"Reddy","year":"1987","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB22","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/00001648-199403000-00003","article-title":"Aspirin use and lung, colon, and breast cancer incidence in a prospective study","volume":"5","author":"Schreinemachers","year":"1994","journal-title":"Epidemiology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB23","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcp.2004.05.031_BIB24","doi-asserted-by":"crossref","first-page":"18563","DOI":"10.1074\/jbc.M010787200","article-title":"Over-expression of COX-2 is sufficient to induce tumorigenesis in transgenic mice","volume":"276","author":"Liu","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB25","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1073\/pnas.121574098","article-title":"Abnormal differentiation of epidermis in transgenic mice constitutively expressing cyclooxygenase-2 in skin","volume":"98","author":"Neufang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2004.05.031_BIB26","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1038\/sj.emboj.7600170","article-title":"Hyperplastic gastric tumors induced by activated macrophages in COX-2\/mPGES-1 transgenic mice","volume":"23","author":"Oshima","year":"2004","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB27","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S0092-8674(00)81988-1","article-title":"Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase-2","volume":"87","author":"Oshima","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB28","first-page":"4705","article-title":"Genetic disruption of Ptgs-1, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice","volume":"60","author":"Chulada","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB29","first-page":"3395","article-title":"Deficiency of either cyclooxygenase (COX)-1 or COX-2 alters epidermal differentiation and reduces mouse skin tumorigenesis","volume":"62","author":"Tiano","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB30","first-page":"2516","article-title":"Cyclooxygenase-2 overexpression in the skin of transgenic mice results in suppression of tumor development","volume":"62","author":"Bol","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB31","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(01)00488-0","article-title":"Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer","volume":"2","author":"Dannenberg","year":"2001","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB32","doi-asserted-by":"crossref","first-page":"33951","DOI":"10.1074\/jbc.M002324200","article-title":"Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells","volume":"275","author":"Shao","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB33","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0300-483X(00)00301-2","article-title":"A causal relationship between unscheduled eicosanoid signaling and tumor development: cancer chemoprevention by inhibitors of arachidonic acid metabolism","volume":"153","author":"Marks","year":"2000","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB34","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0026-895X(24)09255-1","article-title":"Protein kinase C-alpha coordinately regulates cytosolic phospholipase A2 activity and the expression of cyclooxygenase-2 through different mechanisms in mouse keratinocytes","volume":"59","author":"Wang","year":"2001","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB35","doi-asserted-by":"crossref","first-page":"18649","DOI":"10.1074\/jbc.M111415200","article-title":"Cyclooxygenase-2 is overexpressed in HER-2\/neu-positive breast cancer: evidence for involvement of AP-1 and PEA3","volume":"277","author":"Subbaramaiah","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0092-8674(90)90801-K","article-title":"Signal transduction by receptors with tyrosine kinase activity","volume":"61","author":"Ullrich","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB37","first-page":"1189","article-title":"Oncogenic potential of erbB-2 in human mammary epithelial cells","volume":"6","author":"Pierce","year":"1991","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.031_BIB38","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1111\/j.1432-1033.1994.tb18804.x","article-title":"Characterization of the human gene (PTGS2) encoding prostaglandin-endoperoxide synthase 2","volume":"221","author":"Kosaka","year":"1994","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB39","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1101\/gad.6.3.481","article-title":"Molecular cloning and characterization of PEA3, a new member of the Ets oncogene family that is differentially expressed in mouse embryonic cells","volume":"6","author":"Xin","year":"1992","journal-title":"Genes Develop."},{"key":"10.1016\/j.bcp.2004.05.031_BIB40","first-page":"F1","article-title":"Ets transcription factors and human disease","volume":"1377","author":"Dittmer","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2004.05.031_BIB41","doi-asserted-by":"crossref","first-page":"20108","DOI":"10.1074\/jbc.M010692200","article-title":"PEA3 is up-regulated in response to Wnt1 and activates the expression of cyclooxygenase-2","volume":"276","author":"Howe","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB42","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1146\/annurev.immunol.15.1.707","article-title":"Transcription factors of the NFAT family: regulation and function","volume":"15","author":"Rao","year":"1997","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB43","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1681\/ASN.V1271359","article-title":"Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells","volume":"12","author":"Sugimoto","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB44","doi-asserted-by":"crossref","first-page":"23627","DOI":"10.1074\/jbc.M001381200","article-title":"An essential role of the nuclear factor of activated T cells in the regulation of the expression of the cyclooxygenase-2 gene in human T lymphocytes","volume":"275","author":"Iniguez","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB45","doi-asserted-by":"crossref","first-page":"49954","DOI":"10.1074\/jbc.M307964200","article-title":"COX-2 induction by Bradykinin in human pulmonary artery smooth muscle cells is mediated by the cyclic AMP response element through a novel autocrine loop involving endogenous PGE2, EP2 and EP4 receptors","volume":"278","author":"Bradbury","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0014-5793(94)00731-4","article-title":"The cyclic AMP response element plays an essential role in the expression of the human prostaglandin-endoperoxide synthase 2 gene in differentiated U937 monocytic cells","volume":"350","author":"Inoue","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2004.05.031_BIB47","first-page":"6531","article-title":"v-src induction of the TIS10\/PGS2 prostaglandin synthase gene is mediated by an ATF\/CRE transcription response element","volume":"14","author":"Xie","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB48","doi-asserted-by":"crossref","first-page":"31742","DOI":"10.1074\/jbc.271.49.31742","article-title":"Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum","volume":"271","author":"Xie","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB49","first-page":"2522","article-title":"Retinoids and carnosol suppress cyclooxygenase-2 transcription by CREB-binding protein\/p300-dependent and -independent mechanisms","volume":"62","author":"Subbaramaiah","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB50","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1182\/blood-2003-09-3131","article-title":"Role of p300 and PCAF in regulating cyclooxygenase-2 promoter activation by inflammatory mediators","volume":"103","author":"Deng","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2004.05.031_BIB51","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1247\/csf.18.267","article-title":"Peroxisome proliferator-activated receptor (PPAR): structure, mechanisms of activation and diverse functions","volume":"18","author":"Motojima","year":"1993","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bcp.2004.05.031_BIB52","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/0092-8674(95)90193-0","article-title":"15-Deoxy-delta-12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARgamma","volume":"83","author":"Forman","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB53","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0092-8674(95)90194-9","article-title":"A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation","volume":"83","author":"Kliewer","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB54","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1046\/j.1523-1755.2002.00351.x","article-title":"15-Deoxy-Delta12,14-prostaglandin J2 inhibits IL-1beta-induced cyclooxygenase-2 expression in mesangial cells","volume":"61","author":"Sawano","year":"2002","journal-title":"Kidney Int."},{"key":"10.1016\/j.bcp.2004.05.031_BIB55","doi-asserted-by":"crossref","first-page":"4747","DOI":"10.4049\/jimmunol.168.9.4747","article-title":"Selective inhibition of cyclooxygenase-2 expression by 15-deoxy-Delta(12,14)(12,14)-prostaglandin J(2) in activated human astrocytes, but not in human brain macrophages","volume":"168","author":"Janabi","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB56","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/carcin\/22.9.1379","article-title":"Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells","volume":"22","author":"Yang","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2004.05.031_BIB57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1124\/jpet.102.037705","article-title":"Angiotensin II increases expression of cyclooxygenase-2: implications for the function of vascular smooth muscle cells","volume":"303","author":"Hu","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bcp.2004.05.031_BIB58","doi-asserted-by":"crossref","first-page":"12440","DOI":"10.1074\/jbc.M007237200","article-title":"Peroxisome proliferator-activated receptor gamma ligands suppress the transcriptional activation of cyclooxygenase-2. Evidence for involvement of activator protein-1 and CREB-binding protein\/p300","volume":"276","author":"Subbaramaiah","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB59","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1074\/jbc.275.4.2837","article-title":"Regulation of cyclooxygenase-2 by hypoxia and peroxisome proliferators in the corneal epithelium","volume":"275","author":"Bonazzi","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB60","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0006-291X(03)01384-6","article-title":"PPARdelta activation induces COX-2 gene expression and cell proliferation in human hepatocellular carcinoma cells","volume":"308","author":"Glinghammar","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2004.05.031_BIB61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0300-483X(98)00004-3","article-title":"Effect of the peroxisome proliferator ciprofibrate on hepatic cyclooxygenase and phospholipase A2 in rats","volume":"126","author":"Leung","year":"1998","journal-title":"Toxicology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB62","doi-asserted-by":"crossref","first-page":"10911","DOI":"10.1074\/jbc.274.16.10911","article-title":"Inhibition of cyclooxygenase-2 gene expression by p53","volume":"274","author":"Subbaramaiah","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB63","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1054\/bjoc.2000.1607","article-title":"Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer","volume":"84","author":"Leung","year":"2001","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2004.05.031_BIB64","unstructured":"Aggarwal BB, Vilcek J. Tumor necrosis factor: structure, function and mechanism of action. New York: Marcel Dekker Inc., 1992."},{"key":"10.1016\/j.bcp.2004.05.031_BIB65","first-page":"28","article-title":"Nuclear factor-kappa B activation: a question of life and death","volume":"35","author":"Shishodia","year":"2002","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB66","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1096\/fasebj.9.10.7542214","article-title":"Transcriptional regulation of endothelial cell adhesion molecules: NF-\u03baB and cytokine-inducible enhancers","volume":"9","author":"Collins","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB67","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-9440(10)61708-7","article-title":"New insights into the role of nuclear factor-kappaB in cell growth regulation","volume":"159","author":"Chen","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB68","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0092-8674(00)81318-5","article-title":"NF-kappa B: ten years after","volume":"87","author":"Baeuerle","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB69","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/0092-8674(95)90506-5","article-title":"NF-\u03baB: a lesson in family values","volume":"80","author":"Thanos","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB70","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1146\/annurev.immunol.14.1.649","article-title":"The NF-kappa B and I kappa B proteins: new discoveries and insights","volume":"14","author":"Baldwin","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB71","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.1038\/sj.onc.1203239","article-title":"Activators and target genes of Rel\/NF-kappaB transcription factors","volume":"18","author":"Pahl","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.031_BIB72","doi-asserted-by":"crossref","first-page":"27339","DOI":"10.1074\/jbc.274.39.27339","article-title":"The beginning of the end: IkappaB kinase (IKK) and NF-kappaB activation","volume":"274","author":"Karin","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB73","doi-asserted-by":"crossref","first-page":"4547","DOI":"10.1128\/MCB.19.7.4547","article-title":"Bridging the gap: composition, regulation, and physiological function of the I\u03baB kinase complex","volume":"19","author":"Zandi","year":"1999","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB74","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/26254","article-title":"I\u03baAP is a scaffold protein of the I\u03baB kinase complex","volume":"395","author":"Cohen","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2004.05.031_BIB75","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0014-5793(97)01377-X","article-title":"Involvement of NF-\u03baB in the regulation of cyclooxygenase-2 protein expression in LPS-stimulated J774 macrophages","volume":"418","author":"D\u2019Acquisto","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2004.05.031_BIB76","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/sj.onc.1203427","article-title":"Lipopolysaccharide increases cyclo-oxygenase-2 expression in a colon carcinoma cell line through nuclear factor-kappa B activation","volume":"19","author":"Kojima","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.031_BIB77","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1161\/01.CIR.100.12.1330","article-title":"Inhibition of NF-kappaB activation by pyrrolidine dithiocarbamate prevents In vivo expression of proinflammatory genes","volume":"100","author":"Liu","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.bcp.2004.05.031_BIB78","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1095\/biolreprod66.6.1667","article-title":"Nuclear factor \u03baB activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1\u03b2","volume":"66","author":"Yan","year":"2002","journal-title":"Biol. Reprod."},{"key":"10.1016\/j.bcp.2004.05.031_BIB79","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0092-8674(00)81842-5","article-title":"Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway","volume":"88","author":"Lee","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB80","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1128\/MCB.18.1.78","article-title":"Activation of p38 mitogen-activated protein kinase by sodium salicylate leads to inhibition of tumor necrosis factor-induced I\u03baB\u03b1 phosphorylation and degradation","volume":"18","author":"Schwenger","year":"1998","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB81","doi-asserted-by":"crossref","first-page":"20307","DOI":"10.1074\/jbc.274.29.20307","article-title":"Vanadate induction of NF-kappaB involves IkappaB kinase beta and SAPK\/ERK kinase 1 in macrophages","volume":"274","author":"Chen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB82","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/j.1460-2075.1996.tb00542.x","article-title":"The p38\/ERK mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor","volume":"15","author":"Beyaert","year":"1996","journal-title":"EMBO J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB83","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1074\/jbc.273.6.3285","article-title":"p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor","volume":"273","author":"Vanden Berghe","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB84","doi-asserted-by":"crossref","first-page":"29411","DOI":"10.1074\/jbc.273.45.29411","article-title":"Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA\/p65 on serine 529","volume":"273","author":"Wang","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB85","doi-asserted-by":"crossref","first-page":"30858","DOI":"10.1074\/jbc.274.43.30858","volume":"274","author":"Carter","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB86","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/0092-8674(87)90611-8","article-title":"Phorbol ester-inducible genes contain a common cis element recognized by a TPA-modulated trans-acting factor","volume":"49","author":"Angel","year":"1987","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB87","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1073\/pnas.80.11.3183","article-title":"Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein","volume":"80","author":"Van Straaten","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2004.05.031_BIB88","first-page":"129","article-title":"The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation","volume":"1072","author":"Angel","year":"1991","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bcp.2004.05.031_BIB89","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1128\/MCB.17.6.3094","article-title":"Isolation of an AP-1 repressor by a novel method for detecting protein\u2013protein interactions","volume":"17","author":"Aronheim","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB90","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/excr.1999.4685","article-title":"AP-1: one switch for many signals","volume":"253","author":"Wisdom","year":"1999","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB91","doi-asserted-by":"crossref","first-page":"7711","DOI":"10.1073\/pnas.86.20.7711","article-title":"v-maf, a viral oncogene that encodes a \u201cleucine zipper\u201d motif","volume":"86","author":"Nishizawa","year":"1989","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2004.05.031_BIB92","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1073\/pnas.89.1.266","article-title":"A conserved retina-specific gene encodes a basic motif\/leucine zipper domain","volume":"89","author":"Swaroop","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2004.05.031_BIB93","first-page":"2371","article-title":"Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain","volume":"8","author":"Fujiwara","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.031_BIB94","first-page":"700","article-title":"Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun","volume":"14","author":"Kataoka","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB95","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/0092-8674(88)90147-X","article-title":"c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities","volume":"55","author":"Halazonetis","year":"1988","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2004.05.031_BIB96","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/336646a0","article-title":"The role of the leucine zipper in the fos-jun interaction","volume":"336","author":"Kouzarides","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2004.05.031_BIB97","doi-asserted-by":"crossref","first-page":"16483","DOI":"10.1074\/jbc.270.28.16483","article-title":"The regulation of AP-1 activity by mitogen-activated protein kinases","volume":"270","author":"Karin","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB98","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s001090050063","article-title":"Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways","volume":"74","author":"Whitmarsh","year":"1996","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.bcp.2004.05.031_BIB99","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/371171a0","article-title":"c-Fos transcriptional activity stimulated by H-Ras-activated protein kinase distinct from JNK and ERK","volume":"371","author":"Deng","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2004.05.031_BIB100","doi-asserted-by":"crossref","first-page":"31742","DOI":"10.1074\/jbc.271.49.31742","article-title":"Transcriptional regulation of prostaglandin synthase 2 gene expression by platelet-derived growth factor and serum","volume":"271","author":"Xie","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB101","doi-asserted-by":"crossref","first-page":"22941","DOI":"10.1074\/jbc.M101801200","article-title":"Activator protein-1 transcription factor mediates bombesin-stimulated cyclooxygenase-2 expression in intestinal epithelial cells","volume":"276","author":"Guo","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB102","doi-asserted-by":"crossref","first-page":"24965","DOI":"10.1074\/jbc.270.42.24965","article-title":"Transcriptional regulation of human prostaglandin-endoperoxide synthase-2 gene by lipopolysaccharide and phorbol ester in vascular endothelial cells. Involvement of both nuclear factor for interleukin-6 expression site and cAMP response element","volume":"270","author":"Inoue","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB103","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1101\/gad.5.9.1553","article-title":"A family of C\/EBP-related proteins capable of forming covalently linked leucine zipper dimers in vitro","volume":"5","author":"Williams","year":"1991","journal-title":"Genes Develop."},{"key":"10.1016\/j.bcp.2004.05.031_BIB104","doi-asserted-by":"crossref","first-page":"8871","DOI":"10.1073\/pnas.90.19.8871","article-title":"Cell lineage-specific and differentiation-dependent patterns of CCAAT\/enhancer binding protein alpha expression in the gut epithelium of normal and transgenic mice","volume":"90","author":"Chandrasekaran","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2004.05.031_BIB105","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1074\/jbc.272.10.6291","article-title":"CCAAT\/enhancer-binding protein-delta (C\/EBP-delta) is induced in growth-arrested mouse mammary epithelial cells","volume":"272","author":"O\u2019Rourke","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB106","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mc.2940120207","article-title":"Expression of the liver-enriched transcription factors C\/EBP alpha, C\/EBP beta, HNF-1, and HNF-4 in preneoplastic nodules and hepatocellular carcinoma in rat liver","volume":"12","author":"Flodby","year":"1995","journal-title":"Mol. Carcinogen."},{"key":"10.1016\/j.bcp.2004.05.031_BIB107","first-page":"168","article-title":"Regulated expression of three C\/EBP isoforms during adipose conversion of 3T3-L1 cells","volume":"9","author":"Cao","year":"1991","journal-title":"Genes Develop."},{"key":"10.1016\/j.bcp.2004.05.031_BIB108","doi-asserted-by":"crossref","first-page":"4726","DOI":"10.1093\/nar\/23.22.4726","article-title":"Inhibition of cell proliferation by C\/EBP alpha occurs in many cell types, does not require the presence of p53 or Rb, and is not affected by large T-antigen","volume":"23","author":"Hendricks-Taylor","year":"1995","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB109","first-page":"1063","article-title":"Impaired proliferation and tumorigenicity induced by CCAAT\/enhancer-binding protein","volume":"56","author":"Watkins","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB110","first-page":"4475","article-title":"Induction of the mouse serum amyloid A3 gene by cytokines requires both C\/EBP family proteins and a novel constitutive nuclear factor","volume":"14","author":"Huang","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB111","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1016\/S0021-9258(18)42720-2","article-title":"Differential expression of three C\/EBP isoforms in multiple tissues during the acute phase response","volume":"267","author":"Alam","year":"1992","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB112","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/nar\/21.2.289","article-title":"The two C\/EBP isoforms, IL-6DBP\/NF-IL6 and C\/EBP delta\/NF-IL6 beta, are induced by IL-6 to promote acute phase gene transcription via different mechanisms","volume":"21","author":"Ramji","year":"1993","journal-title":"Nucl. Acids Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB113","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1101\/gad.9.2.168","article-title":"Cascade regulation of terminal adipocyte differentiation by three members of the C\/EBP family of leucine zipper proteins","volume":"9","author":"Yeh","year":"1995","journal-title":"Genes Develop."},{"key":"10.1016\/j.bcp.2004.05.031_BIB114","doi-asserted-by":"crossref","first-page":"27686","DOI":"10.1074\/jbc.273.42.27686","article-title":"Transcriptional regulation of cyclooxygenase-2 in mouse skin carcinoma cells. Regulatory role of CCAAT\/enhancer-binding proteins in the differential expression of cyclooxygenase-2 in normal and neoplastic tissues","volume":"273","author":"Kim","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB115","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.4049\/jimmunol.168.8.4055","article-title":"C\/EBP beta gene inactivation causes both impaired and enhanced gene expression and inverse regulation of IL-12 p40 and p35 mRNAs in macrophages","volume":"168","author":"Gorgoni","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB116","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1073\/pnas.90.6.2207","article-title":"Phosphorylation at threonine-235 by a ras-dependent mitogen-activated protein kinase cascade is essential for transcription factor NF-IL6","volume":"90","author":"Nakajima","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2004.05.031_BIB117","doi-asserted-by":"crossref","first-page":"32111","DOI":"10.1074\/jbc.273.48.32111","article-title":"Specific inhibitors of p38 mitogen-activated protein kinase block 3T3-L1 adipogenesis","volume":"273","author":"Engelman","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB118","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1124\/mol.63.3.512","article-title":"Potentiation of lipopolysaccharide-inducible cyclooxygenase 2 expression by C2-ceramide via c-Jun N-terminal kinase-mediated activation of CCAAT\/enhancer binding protein beta in macrophages","volume":"63","author":"Cho","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB119","doi-asserted-by":"crossref","first-page":"12721","DOI":"10.1016\/S0021-9258(18)37813-X","article-title":"Characterization of insulin-stimulated microtubule-associated protein kinase. Rapid isolation and stabilization of a novel serine\/threonine kinase from 3T3-L1 cells","volume":"263","author":"Ray","year":"1988","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB120","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1126\/science.1072682","article-title":"Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases","volume":"298","author":"Johnson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.bcp.2004.05.031_BIB121","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0079-6107(98)00056-X","article-title":"MAP kinase pathways","volume":"71","author":"Cobb","year":"1999","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB122","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1749-6632.2000.tb06313.x","article-title":"Signaling angiogenesis via p42\/p44 MAP kinase cascade","volume":"902","author":"Pages","year":"2000","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1016\/j.bcp.2004.05.031_BIB123","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1006\/scdb.1999.0302","article-title":"MAP kinase-mediated signalling to nucleosomes and immediate-early gene induction","volume":"10","author":"Thomson","year":"1999","journal-title":"Semin. Cell Develop. Biol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB124","doi-asserted-by":"crossref","first-page":"5620","DOI":"10.1074\/jbc.270.10.5620","article-title":"Transforming G protein-coupled receptors potently activate JNK (SAPK). Evidence for a divergence from the tyrosine kinase signaling pathway","volume":"270","author":"Coso","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB125","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1067\/msy.2000.107606","article-title":"Hypertonic saline solution induces prostacyclin production by increasing cyclooxygenase-2 expression","volume":"128","author":"Arbabi","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.bcp.2004.05.031_BIB126","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0022-4804(03)00186-0","article-title":"MAPK regulation of prostaglandin E2 production by lipopolysaccharide-stimulated macrophages is not dependent on nuclear factor kappaB","volume":"113","author":"Lo","year":"2003","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB127","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1038\/sj.onc.1204530","article-title":"Role of p38 MAP kinases and ERK in mediating ultraviolet-B induced cyclooxygenase-2 gene expression in human keratinocytes","volume":"20","author":"Chen","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2004.05.031_BIB128","doi-asserted-by":"crossref","first-page":"37086","DOI":"10.1074\/jbc.M006168200","article-title":"Regulation of cyclooxygenase-2 induction in the mouse uterus during decidualization. An event of early pregnancy","volume":"275","author":"Scherle","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB129","doi-asserted-by":"crossref","first-page":"4930","DOI":"10.4049\/jimmunol.158.10.4930","article-title":"Inhibition of prostaglandin endoperoxide synthase-2 expression in stimulated human monocytes by inhibitors of p38 mitogen-activated protein kinase","volume":"158","author":"Pouliot","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB130","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1042\/bj3301107","article-title":"Lysophosphatidic acid-mediated signal-transduction pathways involved in the induction of the early-response genes prostaglandin G\/H synthase-2 and Egr-1: a critical role for the mitogen-activated protein kinase p38 and for Rho proteins","volume":"330","author":"Reiser","year":"1998","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB131","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-5793(98)01342-8","article-title":"A p38 MAP kinase inhibitor regulates stability of interleukin-1-induced cyclooxygenase-2 mRNA","volume":"439","author":"Ridley","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bcp.2004.05.031_BIB132","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1056\/NEJM200006293422603","article-title":"The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis","volume":"342","author":"Steinbach","year":"2000","journal-title":"Engl. J. Med."},{"key":"10.1016\/j.bcp.2004.05.031_BIB133","first-page":"409","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, against colon carcinogenesis","volume":"58","author":"Kawamori","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB134","first-page":"2101","article-title":"Chemoprevention of breast cancer in rats by celecoxib, a cyclooxygenase 2 inhibitor","volume":"60","author":"Harris","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB135","first-page":"1377","article-title":"Chemotherapeutic evaluation of celecoxib, a cyclooxygenase-2 inhibitor, in a rat mammary tumor model","volume":"7","author":"Alshafie","year":"2000","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2004.05.031_BIB136","first-page":"5599","article-title":"Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats","volume":"60","author":"Grubbs","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB137","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/(SICI)1098-2744(199908)25:4<231::AID-MC1>3.0.CO;2-F","article-title":"Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor, and indomethacin against ultraviolet light-induced skin carcinogenesis","volume":"25","author":"Fischer","year":"1999","journal-title":"Mol. Carcinogen."},{"key":"10.1016\/j.bcp.2004.05.031_BIB138","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1093\/carcin\/20.10.1939","article-title":"Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition","volume":"20","author":"Pentland","year":"1999","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2004.05.031_BIB139","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/carcin\/bgh076","article-title":"Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin","volume":"25","author":"Chun","year":"2004","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2004.05.031_BIB140","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1096\/fj.00-0716fje","article-title":"Celecoxib loses its anti-inflammatory efficacy at high doses through activation of NF-\u03baB","volume":"15","author":"Niederberger","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB141","first-page":"6706","article-title":"Direct evidence for a role of cyclooxygenase 2-derived prostaglandin E2 in human head and neck xenograft tumors","volume":"62","author":"Zweifel","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB142","first-page":"625","article-title":"Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo","volume":"62","author":"Leahy","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB143","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1038\/sj.bjc.6600815","article-title":"Do altering in ornithine decarboxylase activity and gene expression contribute to antiproliferative properties of COX inhibitors?","volume":"88","author":"Ostrowski","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2004.05.031_BIB144","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1042\/bj2340249","article-title":"Recent advances in the biochemistry of polyamines in eukaryotes","volume":"234","author":"Pegg","year":"1986","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB145","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/carcin\/bgg046","article-title":"Celecoxib and difluoromethylornithine in combination have strong therapeutic activity against UV-induced skin tumors in mice","volume":"24","author":"Fischer","year":"2003","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.bcp.2004.05.031_BIB146","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2004.05.031_BIB147","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1096\/fj.01-0299fje","article-title":"COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib","volume":"15","author":"Grosch","year":"2001","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2004.05.031_BIB148","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1158\/0008-5472.CAN-03-2556","article-title":"Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma","volume":"64","author":"Badawi","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB149","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.bcp.2003.12.014","article-title":"Cyclooxygenase-2-dependent and -independent anticarcinogenic effects of celecoxib in human colon carcinoma cells","volume":"67","author":"Maier","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB150","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1053\/gast.2002.32371","article-title":"Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett\u2019s esophagus","volume":"122","author":"Buttar","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB151","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/jnci\/94.8.585","article-title":"Cyclooxygenase-2, player or spectator in cyclooxygenase-2 inhibitor-induced apoptosis in prostate cancer cells","volume":"94","author":"Song","year":"2002","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.bcp.2004.05.031_BIB152","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/00001648-199603000-00017","article-title":"Nonsteroidal antiinflammatory drugs and breast cancer","volume":"7","author":"Harris","year":"1996","journal-title":"Epidemiology"},{"key":"10.1016\/j.bcp.2004.05.031_BIB153","first-page":"1864","article-title":"Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos","volume":"60","author":"Jacoby","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB154","first-page":"5354","article-title":"Prevention of NNK-induced lung tumorigenesis in A\/J mice by acetylsalicylic acid and NS-398","volume":"58","author":"Rioux","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB155","first-page":"1451","article-title":"Increased expression of cyclooxygenase-2 protein and 4-nitroquinoline-1-oxide-induced rat tongue carcinomas and chemopreventive efficacy of a specific inhibitor, nimesulide","volume":"61","author":"Shiotani","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB156","first-page":"165","article-title":"Chemopreventive properties of a selective inducible nitric oxide synthase inhibitor in colon carcinogenesis, administered alone or in combination with celecoxib, a selective cyclooxygenase-2 inhibitor","volume":"62","author":"Rao","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB157","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2613.2002.00228.x","article-title":"Chemopreventive effect of celecoxib and expression of cyclooxygenase-1 and cyclooxygenase-2 on chemically-induced rat mammary tumours","volume":"83","author":"Jang","year":"2002","journal-title":"Int. J. Exp. Pathol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB158","first-page":"3425","article-title":"Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis","volume":"21","author":"Abou-Issa","year":"2001","journal-title":"Anticancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB159","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/gut.2003.021477","article-title":"Chemoprevention of gastric cancer by celecoxib in rats","volume":"53","author":"Hu","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.bcp.2004.05.031_BIB160","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/mc.10141","article-title":"Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment","volume":"38","author":"Wilgus","year":"2003","journal-title":"Mol. Carcinogen."},{"key":"10.1016\/j.bcp.2004.05.031_BIB161","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archderm.138.6.751","article-title":"Celecoxib, a cyclooxygenase 2 inhibitor as a potential chemopreventive to UV-induced skin cancer: a study in the hairless mouse model","volume":"138","author":"Orengo","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.bcp.2004.05.031_BIB162","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0022-5223(03)00790-6","article-title":"Cyclooxygenase-2 inhibition decreases primary and metastatic tumor burden in a murine model of orthotopic lung adenocarcinoma","volume":"126","author":"Diperna","year":"2003","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.bcp.2004.05.031_BIB163","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1097\/00043426-200309000-00007","article-title":"Effect of combined cyclooxygenase-2 and matrix metalloproteinase inhibition on human sarcoma xenografts","volume":"25","author":"Dickens","year":"2003","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"63","key":"10.1016\/j.bcp.2004.05.031_BIB164","first-page":"3032","article-title":"Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice","volume":"15","author":"Saukkonen","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB165","first-page":"5040","article-title":"The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis","volume":"60","author":"Jacoby","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.bcp.2004.05.031_BIB166","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000049449","article-title":"Effects of Celebrex and Zyflo on BOP-induced pancreatic cancer in Syrian hamsters","volume":"2","author":"Wenger","year":"2002","journal-title":"Pancreatology"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520400365X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000629520400365X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:49:38Z","timestamp":1757767778000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000629520400365X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,9]]},"references-count":166,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,9]]}},"alternative-id":["S000629520400365X"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2004.05.031","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2004,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2004.05.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}